pill

Shareholder value Korea to put poison pill adoption on new policy agenda

South Korea will put the adoption of poison pills and dual-class shares on the new policy agenda at a meeting with business leaders this month, wher...

Korean chipmakers Samsung, SK Hynix asked to swallow tough pill over US CHIPS Act

 WASHINGTON, D.C. – South Korean chipmakers on Tuesday expressed deep concerns about the detailed guidelines of the US CHIPS and Science ...

Bio & Pharma SK Chemicals launches uremia itching treatment tablet

SK Chemicals said on Monday that it has launched Remitch in orally disintegrating tablets, a treatment for intractable uremic pruritus (uremia itchi...

Bio & Pharma Korean bio firms look to pills, patches for people who fear needles

Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...

COVID-19 Ildong mulls seeking COVID-19 pill approval from Korea first

Ildong Pharmaceutical Co., a South Korean drugmaker, considers seeking approval for a COVID-19 anti-viral pill from the country as Japan postponed g...

Bio & Pharma Korean drugmakers close to commercializing COVID-19 vaccine, pill

South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...

COVID-19 SK seeks to make Pfizer, Merck COVID-19 pills in CMO deals

SK Inc., the investment and holding company of South Korea’s SK Group, is seeking to make COVID-19 treatment pills developed by Pfizer Inc. an...

Bio Celltrion to co-develop pill-type autoimmune disease drug with UK startup

Biosimilar maker Celltrion Inc. has agreed to develop a tablet-type treatment for autoimmune diseases jointly with the UK biotech startup Intract Phar...